Axsome Therapeutics, Inc. 05464T104 06/05/2026 To approve, by non-binding advisory vote, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 29280.0 0.0 FOR 29280.0 FOR Danaher Corporation 235851102 05/05/2026 To approve on an advisory basis the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 58664.0 0.0 FOR 58664.0 FOR DexCom, Inc. 252131107 05/27/2026 To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 242746.0 0.0 FOR 242746.0 FOR Dianthus Therapeutics, Inc. 252828108 05/21/2026 To approve, on an advisory basis, the compensation paid to our named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 50518.0 0.0 FOR 50518.0 FOR Eli Lilly and Company 532457108 05/04/2026 Approval, on an advisory basis, of the compensation paid to the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 24707.0 0.0 FOR 24707.0 FOR Intuitive Surgical, Inc. 46120E602 04/30/2026 To approve, by advisory vote, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 38075.0 0.0 FOR 38075.0 FOR Johnson & Johnson 478160104 04/23/2026 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 155248.0 0.0 FOR 155248.0 FOR Madrigal Pharmaceuticals, Inc. 558868105 06/17/2026 Advisory vote to approve executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 23505.0 0.0 FOR 23505.0 FOR Nuvalent, Inc. 670703107 06/16/2026 To approve, on an advisory basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 81271.0 0.0 FOR 81271.0 FOR Revolution Medicines, Inc. 76155X100 06/18/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 91878.0 0.0 FOR 91878.0 FOR Tarsus Pharmaceuticals, Inc. 87650L103 06/25/2026 To hold an advisory vote to approve, on a non-binding basis, our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 55460.0 0.0 FOR 55460.0 FOR Teva Pharmaceutical Industries Ltd. 881624209 05/28/2026 To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 277042.0 0.0 FOR 277042.0 FOR Thermo Fisher Scientific Inc. 883556102 05/20/2026 An advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 30699.0 0.0 AGAINST 30699.0 AGAINST United Therapeutics Corporation 91307C102 06/26/2026 Advisory resolution to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 8810.0 0.0 FOR 8810.0 FOR Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 44919.0 0.0 FOR 44919.0 FOR